Anti-HLA class I antibody–mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells

Mauiyyedi, 2002, Humoral rejection in kidney transplantation, Curr Opin Nephrol Hypertens, 11, 609, 10.1097/00041552-200211000-00007

Joosten, 2003, Pathogenesis of chronic allograft rejection, Transpl Int, 16, 137, 10.1111/j.1432-2277.2003.tb00277.x

Paul, 1992, Chronic vascular rejection of the heart and the kidney—have rational treatment options emerged?, Transplantation, 53, 1169, 10.1097/00007890-199206000-00001

Bian, 1997, Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation, Hum Immunol, 53, 90, 10.1016/S0198-8859(96)00272-8

Bian, 1998, Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation, Int Immunol, 10, 1315, 10.1093/intimm/10.9.1315

Bian, 1999, Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells, J Immunol, 163, 1010, 10.4049/jimmunol.163.2.1010

Bian, 1999, Anti-HLA antibodies transduce proliferative signals in endothelial cells and smooth muscle cells, Transplant Proc, 31, 1924, 10.1016/S0041-1345(99)00206-7

Harris, 1997, Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies, J Immunol, 159, 5697, 10.4049/jimmunol.159.11.5697

Jin, 2002, Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin and focal adhesion kinase in an actin dependent manner, J Immunol, 168, 5415, 10.4049/jimmunol.168.11.5415

Schaller, 2001, Biochemical signals and biological responses elicited by the focal adhesion kinase, Biochim Biophys Acta, 1540, 1, 10.1016/S0167-4889(01)00123-9

Michaels, 2003, Humoral rejection in cardiac transplantation, J Heart Lung Transplant, 22, 58, 10.1016/S1053-2498(02)00472-2

Coffer, 1998, Protein kinase B (c-Akt), Biochem J, 335, 1, 10.1042/bj3350001

Brazil, 2001, Ten years of protein kinase B signalling, Trends Biochem Sci, 26, 657, 10.1016/S0968-0004(01)01958-2

Datta, 1999, Cellular survival, Genes Dev, 13, 2905, 10.1101/gad.13.22.2905

Kandel, 1999, The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB, Exp Cell Res, 253, 210, 10.1006/excr.1999.4690

Owen, 1999, Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2, Mol Cell Biol, 19, 4806, 10.1128/MCB.19.7.4806

Salazar, 2001, Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397, J Biol Chem, 276, 17788, 10.1074/jbc.M100984200

Parsons, 2003, Focal adhesion kinase, J Cell Sci, 116, 1409, 10.1242/jcs.00373

Yano, 1998, Calcium promotes cell survival through CaM-K kinase activation of the protein–kinase-B pathway, Nature, 396, 584, 10.1038/25147

Katso, 2001, Cellular function of phosphoinositide 3-kinases, Annu Rev Cell Dev Biol, 17, 615, 10.1146/annurev.cellbio.17.1.615

Frisch, 2001, Anoikis mechanisms, Curr Opin Cell Biol, 13, 555, 10.1016/S0955-0674(00)00251-9

Madge, 2000, A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells, J Biol Chem, 275, 15458, 10.1074/jbc.M001237200

Kim, 2001, Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1, Mol Cell Biol, 21, 893, 10.1128/MCB.21.3.893-901.2001

Kulik, 1997, Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt, Mol Cell Biol, 17, 1595, 10.1128/MCB.17.3.1595

Grad, 2000, Regulation of Bcl-xL, Curr Opin Oncol, 12, 543, 10.1097/00001622-200011000-00006

Skov, 1998, Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells, Blood, 91, 3566, 10.1182/blood.V91.10.3566

Patel, 1969, Significance of the positive crossmatch test in kidney transplantation, N Engl J Med, 280, 735, 10.1056/NEJM196904032801401

Bach, 1997, Accommodation of vascularized xenografts, Nat Med, 3, 196, 10.1038/nm0297-196

Hancock, 1998, Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes, Nat Med, 4, 1392, 10.1038/3982

Contreras, 2001, Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement, Surgery, 130, 166, 10.1067/msy.2001.115828

Badrichani, 1999, Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB, J Clin Invest, 103, 543, 10.1172/JCI2517

Ferran, 1998, A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor–mediated apoptosis, Blood, 91, 2249, 10.1182/blood.V91.7.2249

Brouard, 2000, Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis, J Exp Med, 192, 1015, 10.1084/jem.192.7.1015

Katori, 2002, Heme oxygenase-1 system in organ transplantation, Transplantation, 74, 905, 10.1097/00007890-200210150-00001

Salama, 2001, Transplant accommodation in highly sensitized patients, Am J Transplant, 1, 260, 10.1034/j.1600-6143.2001.001003260.x

Ratkovec, 1992, Outcome of cardiac transplant recipients with a positive donor-specific crossmatch—preliminary results with plasmapheresis, Transplantation, 54, 651, 10.1097/00007890-199210000-00017

Pisani, 1999, Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation, J Heart Lung Transplant, 18, 701, 10.1016/S1053-2498(99)00022-4

Sonnenday, 2002, Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match, Transplant Proc, 34, 1614, 10.1016/S0041-1345(02)03044-0

Alexandre, 1985, Human ABO-incompatible living donor renal homografts, Neth J Med, 28, 231

Palmer, 1989, Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation, Lancet, 1, 10, 10.1016/S0140-6736(89)91672-3

Kupin, 1991, Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients, Transplantation, 51, 324, 10.1097/00007890-199102000-00010

Mendez, 1992, Successful living-related ABO incompatible renal transplant using the BIOSYNSORB Immunoadsorption Column, Transplant Proc, 24, 1738

Ross, 1993, Renal transplantation following immunoadsorption in highly sensitized recipients, Transplantation, 55, 785, 10.1097/00007890-199304000-00019

Reisaeter, 1995, Pretransplant plasma exchange or immunoadsorption facilitates renal transplantation in immunized patients, Transplantation, 60, 242, 10.1097/00007890-199508000-00006

Nath, 1999, HLA class I–mediated induction of cell proliferation involves cyclin E-mediated inactivation of Rb function and induction of E2F activity, J Immunol, 162, 5351, 10.4049/jimmunol.162.9.5351

Maher, 1996, Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2, J Cell Biol, 134, 529, 10.1083/jcb.134.2.529